Katrina Sleeman
Overview
Explore the profile of Katrina Sleeman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edun O, Okell L, Chun H, Bissek A, Ndongmo C, Shang J, et al.
PLOS Glob Public Health
. 2024 Apr;
4(4):e0003030.
PMID: 38573931
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia...
2.
Hladik W, Stupp P, McCracken S, Justman J, Ndongmo C, Shang J, et al.
PLoS One
. 2023 Jun;
18(6):e0275560.
PMID: 37363921
Background: We examined the epidemiology and transmission potential of HIV population viral load (VL) in 12 sub-Saharan African countries. Methods: We analyzed data from Population-based HIV Impact Assessments (PHIAs), large...
3.
Rottinghaus Romano E, Sleeman K, Hall-Eidson P, Zeh C, Bhairavabhotla R, Zhang G, et al.
Emerg Infect Dis
. 2022 Dec;
28(13):S59-S68.
PMID: 36502414
The US President's Emergency Plan for AIDS Relief (PEPFAR) supports molecular HIV and tuberculosis diagnostic networks and information management systems in low- and middle-income countries. We describe how national programs...
4.
Farley S, Wang C, Bray R, Low A, Delgado S, Hoos D, et al.
J Int AIDS Soc
. 2022 Sep;
25 Suppl 4:e26005.
PMID: 36176030
Introduction: Achieving optimal HIV outcomes, as measured by global 90-90-90 targets, that is awareness of HIV-positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among...
5.
Hakim A, Bolo A, Coy K, Achut V, Katoro J, Caesar G, et al.
BMC Public Health
. 2022 Jan;
22(1):132.
PMID: 35045854
Background: Little is known about HIV in South Sudan and even less about HIV among female sex workers (FSW). We characterized progress towards UNAIDS 90-90-90 targets among female sex workers...
6.
Jonnalagadda S, Auld A, Jahn A, Saito S, Bello G, Sleeman K, et al.
Pediatr Infect Dis J
. 2021 Aug;
40(11):1011-1018.
PMID: 34382613
Background: Control of the pediatric HIV epidemic is hampered by gaps in diagnosis and linkage to effective treatment. The 2015-2016 Malawi Population-based HIV impact assessment data were analyzed to identify...
7.
Hakim A, Tippett Barr B, Kinchen S, Musuka G, Manjengwa J, Munyati S, et al.
J Acquir Immune Defic Syndr
. 2021 Jul;
88(3):272-281.
PMID: 34321414
Objective: We present findings from the nationally representative Zimbabwe Population-based HIV Impact Assessment that characterize Zimbabwe's progress toward the Joint United Nations Programme on HIV/AIDS 90-90-90 targets. Design: We conducted...
8.
Domaoal R, Sleeman K, Sawadogo S, Dzinamarira T, Frans N, Shatumbu S, et al.
J Acquir Immune Defic Syndr
. 2021 Jun;
87(Suppl 1):S67-S72.
PMID: 34166314
Background: In the population-based HIV impact assessment surveys, early infant diagnosis (EID) was provided to infants <18 months without a prior diagnosis. For the Namibia population-based HIV impact assessment (NAMPHIA),...
9.
Patel H, Duong Y, Birhanu S, Dobbs T, Lupoli K, Moore C, et al.
J Acquir Immune Defic Syndr
. 2021 Jun;
87(Suppl 1):S17-S27.
PMID: 34166309
Background: Conducting HIV surveys in resource-limited settings is challenging because of logistics, limited availability of trained personnel, and complexity of testing. We described the procedures and systems deemed critical to...
10.
Lecher S, Fonjungo P, Ellenberger D, Toure C, Alemnji G, Bowen N, et al.
MMWR Morb Mortal Wkly Rep
. 2021 May;
70(21):775-778.
PMID: 34043612
One component of the Joint United Nations Programme on HIV/AIDS (UNAIDS) goal to end the HIV/AIDS epidemic by 2030, is that 95% of all persons receiving antiretroviral therapy (ART) achieve...